Novartis India extends access to its medicines in India with Dr Reddy’s Laboratories
Novartis India recently announced an exclusive sales and distribution agreement with Dr Reddy’s Laboratories for a few of its established medicines which include the Voveran range, the Calcium range and Methergine, Novartis notified via a statement.
February 14, 2022
by ExpressPharma
Early risers: life-changing medical scheme given legal revitalisation
Boost for patients with life-threatening conditions who require access to medicines not yet authorised for marketing.
February 3, 2022
by pharmatimes
UK could “become the world’s foremost nation for drug security,” says FarmaTrust
The global medical authentication provider is urging the government to secure the UK’s medicines supply by modernising the system with blockchain technologies.
January 15, 2021
by europeanpharmaceuticalreview
NICE initiates new Innovative Licensing and Access Pathway for medicines
The new pathway developed by NICE for medicines to go from clinical trials to NHS patients is now in action.
January 7, 2021
by europeanpharmaceuticalreview
NICE collaboration creates new route for medicines approval
A collaboration between the UK's National Institute for Health and Care Excellence (NICE), drug regulators, the NHS and equivalent organisation in Scotland has opened a new route for medicine approval in the UK.
January 6, 2021
by pharmatimes
RPS in discussions with government to improve patient access to medicines
The Royal Pharmaceutical Society (RPS) has met with government officials to discuss changes in legislation that would enable pharmacists to make minor changes to prescriptions.
December 8, 2020
by pharmatimes
AIOCD writes to PM about possible shortage of essential medicines due to farmers agitation
Requests government to ensure supply of medicines by providing secure passage to medicine transporters.
December 7, 2020
by expresspharma
EC announces new Pharmaceutical Strategy for Europe
The strategy outlines actions to strengthen EU supply chains, encourage innovation and ensure medicines are affordable and sustainable.
November 27, 2020
by europeanpharmaceuticalreview
Uni of Exeter partners with MDC to accelerate academic medicines research
The University of Exeter and Medicines Discovery Catapult (MDC) have partnered to accelerate medicines research and development to maximise the impact and value of basic medical research.
November 16, 2020
by pharmatimes
FDA publishes list of essential medicines and medical countermeasures
The agency has compiled a list of essential medicines, medical countermeasures and critical inputs, as directed by Trump’s executive order in August.
November 5, 2020
by europeanpharmaceuticalreview
Pharma products worth Rs 358 cr sold through Jan Aushadhi stores in this fiscal
Likely to surpass sales of Rs 600 crore for the entire fiscal year against Rs 419 crore in 2019-20.
November 4, 2020
by expresspharma
Construction Starts on the Medicines Manufacturing Innovation Center
CPI has started construction at the Medicines Manufacturing Innovation Center in Renfrewshire, Scotland. The new facility will offer solutions in small molecule and pharmaceutical manufacturing, aiming to accelerate the development and ...
October 28, 2020
by contractpharma